Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikwunga Wonodi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2007
Tardive dyskinesia in children treated with atypical antipsychotic medicationsIkwunga Wonodi, Gloria Reeves, Dana Carmichael, et al.
Behavioral and Brain Functions : BBF|December 19, 2006
Lack of association between COMT gene and deficit/nondeficit schizophreniaIkwunga Wonodi, Braxton D Mitchell, O Colin Stine, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2008
Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophreniaIkwunga Wonodi, L Elliot Hong, O Colin Stine, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2010
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineElaine Weiner, Robert R Conley, M Patricia Ball, et al.
Archives of General Psychiatry|July 6, 2011
Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypesIkwunga Wonodi, O Colin Stine, Korrapati V Sathyasaikumar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophreniaL Elliot Hong, Ikwunga Wonodi, Matthew T Avila, et al.
The Psychiatric Quarterly|June 24, 2017
Clozapine in Reducing Aggression and Violence in Forensic PopulationsKathleen Patchan, Gopal Vyas, Ann L Hackman, et al.
Archives of General Psychiatry|August 4, 2011
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorderL Elliot Hong, Gunvant K Thaker, Robert P McMahon, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2007
Tardive dyskinesia in children treated with atypical antipsychotic medicationsIkwunga Wonodi, Gloria Reeves, Dana Carmichael, et al.
Behavioral and Brain Functions : BBF|December 19, 2006
Lack of association between COMT gene and deficit/nondeficit schizophreniaIkwunga Wonodi, Braxton D Mitchell, O Colin Stine, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 17, 2008
Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophreniaIkwunga Wonodi, L Elliot Hong, O Colin Stine, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2010
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapineElaine Weiner, Robert R Conley, M Patricia Ball, et al.
Archives of General Psychiatry|July 6, 2011
Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypesIkwunga Wonodi, O Colin Stine, Korrapati V Sathyasaikumar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophreniaL Elliot Hong, Ikwunga Wonodi, Matthew T Avila, et al.
The Psychiatric Quarterly|June 24, 2017
Clozapine in Reducing Aggression and Violence in Forensic PopulationsKathleen Patchan, Gopal Vyas, Ann L Hackman, et al.
Archives of General Psychiatry|August 4, 2011
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorderL Elliot Hong, Gunvant K Thaker, Robert P McMahon, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 3